SUMMARY In heart failure both functional capacity and prognosis are primarily determined by the degree of pump dysfunction. Although data on haemodynamic function at rest may indicate impaired cardiac function, they do not assess the capacity ofthe heart to respond to stress. Maximal bicycle ergometry and incremental intravenous inotropic stimulation in 31 patients with moderately severe heart failure were evaluated as methods of stressing the heart to determine cardiac pumping capability, which is defined as the cardiac power obtained during maximal stimulation. There was good agreement between the cardiac pumping capabilities assessed by these two methods. Maximal cardiac power output was better than maximal cardiac output and left ventricular stroke work index in representing cardiac pumping capability, because it was less dependent on the type of stimulation used during evaluation.
Inotropic challenge is at least as effective as exercise testing in assessing cardiac pumping capability in heart failure, and may be a better method in patients who find physical exercise difficult.
The primary defect in heart failure is the inability of the cardiac pump to deliver sufficient hydraulic energy to maintain the circulation required by the metabolism during exercise and, when failure becomes more severe, at rest as well.' Variables such as left ventricular ejection fraction, cardiac index, and left ventricular stroke work index are often measured to assess the extent ofthe primary defect.23 Unfortunately, these variables correlated poorly with exercise capacity45 and prognosis in individual patients with heart failure. '6 An alternative method of evaluating cardiac impairment has been proposed.7 It was suggested that cardiac power output is, from the point ofview of fluid dynamics, the most logical variable to represent cardiac performance. Whether it reflects cardiac function more closely than the more commonly used variables, such as cardiac index and left ventricular stroke work index, remains to be seen. In theory, how good the heart is as a pump can be best represented by the maximum hydraulic power output achieved by the heart during maximal stimulation, and this value is termed the cardiac pumping capability. The maximum cardiac power output during exercise testing (CPOE) was that obtained when the patient was performing at maximal exercise workload. The maximum cardiac power output during dobutamine infusion (CPOD) was determined by the highest cardiac power output value obtained during the incremental dobutamine stimulation.
Statistical analysis was by Student's paired t test. Differences were taken to be significant at p < 0 05. Results are expressed as mean (1 SD). We used the statistical method of Bland and Altman' to assess the agreement between the two methods of evaluating cardiac pumping capability (dobutamine and exercise challenge). Figure 1 shows cardiac power output during incremental dobutamine infusion in three representative patients. The increases in cardiac power output were more prominent at the lower doses of dobutamine, from 0 to 7 5 pg/kg/min. Above 10 pg/kg/min the increases in cardiac power output with increments of dobutamine tended to reach a plateau. These patients had not been exposed to dobutamine and had not developed tolerance to it. When tolerance developed (for example after more than 24 hours of dobutamine infusion at > 10 pg/kg/min), > 20 ug/kg/ min) were required to attain the peak cardiac power output. CPOD was unambiguously identified for each patient because values either reached a plateau at high doses or showed a peak followed by a decline.
The statistical method of Bland and Altman5 showed good agreement between the cardiac pumping capability as evaluated by measuring peak cardiac performance (represented by peak cardiac power output) during maximal dobutamine challenge and maximal exercise (fig 2a) . When cardiac output was used to represent cardiac performance (fig 2b) the scatter of the points around the mean was similar, with the coefficient ofvariation ofthe differences (SD of differences/mean ofthe average peak values) being 0 19 in both assessments. However, the mean difference between CPOD and CPOE was closer to zero than that between COD and COE. There were more points above than below zero in fig 2b. In other words, the peak cardiac output measured during dobutamine challenge tended to be greater than that measured during exercise. The heart of a patient in cardiac failure has limited functional capacity. Measurement The data shown in figs 2a and b suggest that cardiac power output is a better variable to represent cardiac pumping capability than cardiac output. For similar degree of cardiac stimulation, cardiac pumping capability during dobutamine challenge tended to be overestimated if cardiac output were used as the indicator of cardiac performance. This was because at peak stimulation blood pressure was significantly lower with dobutamine challenge than with exercise (table). There was a tendency for dobutamine to produce greater systemic arterial vasodilatation than exercise. Any drug that causes appreciable vasodilatation is liable to exaggerate cardiac output because the heart's capacity for generating pressure is converted into a capacity for generating flow.
Like cardiac power output, left ventricular stroke work index accounts for the capacity of the heart to generate both pressure and flow. So we were not surprised to find that the scatters of the differences above and below zero in fig 2c were almost equal. Left ventricular stroke work index is energy output per stroke whereas cardiac power output is energy output per unit time. Thus unlike cardiac power output, left ventricular stroke work index does not contain the factor heart rate. When heart rate is held constant these two measures of cardiac pumping capacity are equal. As far as maintaining the circulation is concerned, it does not matter how much hydraulic energy per stroke the heart delivers into the circulation, as long as the total delivered per unit time is sufficient to replenish the energy lost in the vasculature, and able to maintain organ perfusion and metabolism in tissues. Thus for any two hearts with the same limitation in generating stroke work, the one that is capable of a greater increase in heart rate would be able to impart more hydraulic energy into the vasculature and thus maintain a higher level of circulation and metabolism. Hence from the theoretical point of view, cardiac power output would be expected to be a better functional representation of cardiac pumping capability than left ventricular stroke work index. In patients with ischaemic cardiac failure, it is not uncommon to see excessive or inadequate chronotropic responses to exercise. The greater scatter of the points in fig 2c than in fig 2a suggests that the chronotropic responses ofthe hearts to dobutamine and exercise were different. Also, in fig 2c, peak left ventricular stroke work index was apparently higher with dobutamine challenge than with exercise when values were < 35 g.m.m'n but the 24 converse was true for higher values (> 50 g.m.m'). This implies that the use of left ventricular stroke work index as a measure of cardiac pumping capability depends on the mode of stimulation used and whether such stimulation can induce an appropriate chronotropic response.
PHARMACOLOGICAL AGENTS TO STIMULATE THE HEART Dobutamine was chosen as the stimulating agent primarily because it was the most commonly used intravenous positive inotropic agent in the treatment of heart failure in our coronary care unit. As an adrenergic agonist it resembles the activity of endogenous catecholamines.910 One concern is that, as there is appreciable f adrenoceptor down regulation in severe heart failure," adrenergic agonists may not be the ideal agent to use. The combined use of dobutamine with a phosphodiesterase inhibitor'2 may circumvent this problem, but the combined arrhythmogenic effects of these drugs have not been ascertained. Furthermore, it may be argued that when patients exercise they have to rely on the cardiac response to adrenergic drive to augment their cardiac performance. Hence, from the functional point ofview, the amount ofcardiac reserve available via adrenergic stimulation is that which is of clinical and functional relevance.
A COMPARISON OF PHARMACOLOGICAL AND PHYSIOLOGICAL STIMULATION
This study showed that cardiac pumping capability measured during dobutamine challenge correlated well with that measured during symptom limited bicycle exercise testing, but there are advantages and disadvantages with both methods. The disadvantage of exercise testing lies in the difficulty in determining the true maximum exercise. It has been proposed that one way of identifying this point is to use the plateau ofoxygen consumption as maximum exercise is approached," '4 but this proposal has been challenged." In contrast, CPOD can be easily identified during incremental dobutamine infusion (fig 1) . Furthermore, since CPOD can be unambiguously determined (fig 1) , it would be reasonable to propose that a necessary (but not sufficient) condition which must be satisfied before it can be claimed that the point of maximum exercise has been reached, is the attainment of CPOE that is greater than CPOD.
Different exercise protocols may stress the heart differently, for example, more rapid increases in workload lead to earlier attainment of the maximum workload and a greater value of CPOE.7'6 During incremental dobutamine infusion, however, the ventricular filling pressures tend to decrease, which implies that CPOD might have been higher had it overlap of values between survivors and nonsurvivors limited the usefulness of these variables as discriminators in individual patients.'6 Unfortunately, cardiac function was evaluated at basal resting states in these studies. An indirect measure ofcardiac function that uses peak oxygen uptake during maximal exercise was shown to be a good prognostic index.2' The reason for this is that peak oxygen uptake is obtained during maximal stress. In other words, it is an indirect measure of the cardiac pumping capacity. However, it is also dependent on other factors as well, notably the regional distribution ofblood flow and the way that exercising skeletal muscle consumes oxygen, and these factors are not known to influence prognosis unless the peripheral tissues become ischaemic at rest in terminal heart failure. Hence, a more direct measure of cardiac pumping capacity would be expected to be a better indicator of prognosis.'
The serum concentration of noradrenaline is also an indirect marker of cardiac dysfunction, and it has also been shown to be quite a good indicator of prognosis." ' The higher the noradrenaline concentration in severe heart failure the more likely is downregulation ofthe ,B adrenoceptors. " The evaluation of cardiac responsiveness to adrenergic stimulation (for example, dobutamine infusion) combines the information on cardiac pumping capacity and the sympathetic neurohormonal state of a patient with heart failure.' It is therefore not surprising that this method of assessing prognosis is much more accurate than other methods of determining prognosis. What was not clear from the previous study was whether cardiac pumping capacity determined by dobutamine challenge is related to functional cardiac pumping capacity. This study showed a good agreement between the pharmacologically determined cardiac pumping capacity and physiologically determined cardiac pumping capacity. We can infer from this that the cardiac pumping capacity assessed by dobutamine challenge is a true indication of the functional capacity of the impaired heart during exercise. We therefore recommend that whenever a patient requires inotropic support, an incremental infusion of dobutamine should be given because the measurement of cardiac pumping capacity obtained will give important information on prognosis, which will help in deciding the future management of the patient.
The concept of evaluating cardiac function by cardiac pumping capacity is new. Its clinical utility is based on the understanding that measurement of cardiac function in the basal unstressed states is uncertain because of the variable degrees of activation ofneurohormonal compensatory mechanisms on the one hand and on the other the variable states of somnolence or excitation of the patient during measurement. To avoid ambiguity, evaluation must be performed at maximal stress. The results of this study suggest that pharmacological stress is as good as physiological stress. The variable chosen to represent cardiac performance at this maximal point must not only reflect some isolated aspects of cardiac function (for example myocardial contractility) but also the overall integrity of the cardiac pumping. We found that cardiac power output was a better indicator of overall cardiac performances than cardiac index and left ventricular stroke work index. 
